Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
2(8%)
Results Posted
59%(10 trials)
Terminated
1(4%)

Phase Distribution

Ph not_applicable
2
8%
Ph phase_1
4
17%
Ph phase_3
3
13%
Ph phase_2
10
42%
Ph phase_4
3
13%

Phase Distribution

4

Early Stage

10

Mid Stage

6

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
4(18.2%)
Phase 2Efficacy & side effects
10(45.5%)
Phase 3Large-scale testing
3(13.6%)
Phase 4Post-market surveillance
3(13.6%)
N/ANon-phased studies
2(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.4%

17 of 18 finished

Non-Completion Rate

5.6%

1 ended early

Currently Active

2

trials recruiting

Total Trials

24

all time

Status Distribution
Active(4)
Completed(17)
Terminated(1)
Other(2)

Detailed Status

Completed17
Not yet recruiting2
Terminated1
unknown1
Suspended1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
2
Success Rate
94.4%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (18.2%)
Phase 210 (45.5%)
Phase 33 (13.6%)
Phase 43 (13.6%)
N/A2 (9.1%)

Trials by Status

completed1771%
not_yet_recruiting28%
terminated14%
unknown14%
suspended14%
active_not_recruiting14%
recruiting14%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT05044962Not Applicable

Kuwa Free! - Live Free!

Recruiting
NCT03537768Phase 4

Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg

Terminated
NCT06727734Phase 3

Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception

Not Yet Recruiting
NCT02722421Phase 2

Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women

Completed
NCT01686126Phase 2

Improving the Treatment for Women With Early Stage Cancer of the Uterus

Active Not Recruiting
NCT06492889Phase 2

Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens

Not Yet Recruiting
NCT00131885Phase 4

Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel

Completed
NCT02203331Phase 2

Bay98-7196, Dose Finding / POC Study

Completed
NCT01789879Phase 2

A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy

Completed
NCT00551616Phase 3

Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception

Completed
NCT04676776Phase 2

Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"

Unknown
NCT00445887Phase 2

Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer

Completed
NCT03778359

Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis

Completed
NCT01623466Phase 1

Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches

Completed
NCT02480647Phase 4

Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis

Completed
NCT02599077Phase 2

Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas

Suspended
NCT01570244Phase 1

Drug-drug Interaction of BI 201335 and Microgynon

Completed
NCT02159131Phase 1

Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects

Completed
NCT00669396Not Applicable

Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception

Completed
NCT01328184Phase 1

Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon

Completed

Drug Details

Intervention Type
DRUG
Total Trials
24